Non-invasive prenatal diagnosis of aneuploidies: New technologies and clinical applications

Genome Medicine

Volumn 4, Issue 5, 2012, Pages

  Papageorgiou, Elisavet A ^a,b   Patsalis, Philippos C ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b NIPD Genetics Ltd   (Cyprus)

Author keywords

Fetal DNA; Fetal specific methylation; Next generation sequencing; NIPD clinical implementation; Non invasive prenatal diagnosis

Indexed keywords

BISULFITE; FORMALDEHYDE; MESSENGER RNA; RESTRICTION ENDONUCLEASE;

ANEUPLOIDY; CIRCULATION; CLINICAL PRACTICE; DNA METHYLATION; DOWN SYNDROME; EDWARDS SYNDROME; HUMAN; IMMUNOPRECIPITATION; MATERNAL CIRCULATION; MATERNAL PLASMA; NON INVASIVE PRENATAL DIAGNOSIS; PATAU SYNDROME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW;

EID: 84861357367     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm345     Document Type: Review

References (119)

1. Hulten MA, Dhanjal S, Pertl B. Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction 2003, 126:279-97. 10.1530/rep.0.1260279, 12968936.
2. Grimshaw G, Szczepura A, Hultén M, MacDonald F, Nevin N, Sutton F, Dhanjal S. Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess 2003, 7:1-146.
3. Divane A, Carter NP, Spathas DH, Ferguson-Smith MA. Rapid prenatal diagnosis of aneuploidy from uncultured amniotic fluid cells using five-colour fluorescence in situ hybridization. Prenat Diagn 1994, 14:1061-1069. 10.1002/pd.1970141109, 7877954.
4. Driscoll DA, Gross S. Clinical practice. Prenatal screening for aneuploidy. N Engl J Med 2009, 360:2556-2562. 10.1056/NEJMcp0900134, 19516035.
5. Hassold T, Abruzzo M, Adkins K, Griffin D, Merrill M, Millie E, Saker D, Shen J, Zaragoza M. Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen 1996, 28:167-175. 10.1002/(SICI)1098-2280(1996)28:3<167::AID-EM2>3.0.CO;2-B, 8908177.
6. Griffiths AJF, Jeffrey H, Suzuki DT, Lewontin RC, Gelbart WM. Chromosome mutation II: changes in chromosome number. An Introduction to Genetic Analysis 2000, New York: WH Freeman and Company, Griffith AJF, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM, 7.
7. Valenti C, Schutta EJ, Kehaty T. Prenatal diagnosis of Down's syndrome. Lancet 1968, 2:220.
8. Wapner RJ. Invasive prenatal diagnostic techniques. Semin Perinatol 2005, 29:401-404. 10.1053/j.semperi.2006.01.003, 16533654.
9. Chachkin CJ. What potent blood: non-invasive prenatal genetic diagnosis and the transformation of modern prenatal care. Am J Law Med 2007, 33:9-53.
10. Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006, 108:612-616. 10.1097/01.AOG.0000232512.46869.fc, 16946222.
11. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007, 110:687-694. 10.1097/01.AOG.0000278820.54029.e3, 17766619.
12. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487. 10.1016/S0140-6736(97)02174-0, 9274585.
13. Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol 2005, 106:841-844. 10.1097/01.AOG.0000179477.59385.93, 16199645.
14. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998, 339:1734-1738. 10.1056/NEJM199812103392402, 9845707.
15. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775. 10.1086/301800, 1377040, 9529358.
16. Lun FM, Chiu RW, Allen Chan KC, Yeung Leung T, Kin Lau T, Dennis Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008, 54:1664-1672. 10.1373/clinchem.2008.111385, 18703764.
17. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, Lo KW, Huang DW, Lo YM. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004, 50:88-92. 10.1373/clinchem.2003.024893, 14709639.
18. Poon LL, Leung TN, Lau TK, Chow KC, Lo YM. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 2002, 48:35-41.
19. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, Foo CH, Xie B, Tsui NB, Lun FM, Zee BC, Lau TK, Cantor CR, Lo YM. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008, 105:20458-20463. 10.1073/pnas.0810641105, 2600580, 19073917.
20. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008, 105:16266-16271. 10.1073/pnas.0808319105, 2562413, 18838674.
21. Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, Chan LY, Oudejans CB, Ding C, Lo YM. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005, 102:14753-14758. 10.1073/pnas.0503335102, 1253547, 16203989.
22. Old RW, Crea F, Puszyk W, Hulten MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 2007, 15:227-235. 10.1016/S1472-6483(10)60713-4, 17697502.
23. Chim SS, Jin S, Lee TY, Lun FM, Lee WS, Chan LY, Jin Y, Yang N, Tong YK, Leung TY, Lau TK, Ding C, Chiu RW, Lo YM. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 2008, 54:500-511. 10.1373/clinchem.2007.098731, 18202156.
24. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW, Lo YM. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003, 100:4748-4753. 10.1073/pnas.0637450100, 153627, 12644709.
25. Avent ND, Plummer ZE, Madgett TE, Maddocks DG, Soothill PW. Post-genomics studies and their application to non-invasive prenatal diagnosis. Semin Fetal Neonatal Med 2008, 13:91-98. 10.1016/j.siny.2007.12.011, 18249591.
26. Hawes CS, Suskin HA, Petropoulos A, Latham SE, Mueller UW. A morphologic study of trophoblast isolated from peripheral blood of pregnant women. Am J Obstet Gynecol 1994, 170:1297-1300.
27. Schueler PA, Yamanishi DT, Pearson J, Lee Y, Wu X, Hashima S, Madlansacay MR, Cain CA, Collarini EJ, Foltz L, Mahoney W. Inconsistency of fetal trophoblast cells in first trimester maternal peripheral blood prevents non-invasive fetal testing using this cell target. Placenta 2001, 22:702-715. 10.1053/plac.2001.0704, 11597190.
28. Ciaranfi A, Curchod A, Odartchenko N. [Post-partum survival of fetal lymphocytes in the maternal blood]. Schweiz Med Wochenschr 1977, 107:134-138.
29. Pearson HA. Life-span of the fetal red blood cell. J Pediatr 1967, 70:166-171. 10.1016/S0022-3476(67)80410-4, 5334979.
30. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990, 87:3279-3283. 10.1073/pnas.87.9.3279, 53883, 2333281.
31. Sohda S, Arinami T, Hamada H, Nakauchi H, Hamaguchi H, Kubo T. The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. Prenat Diagn 1997, 17:743-752. 10.1002/(SICI)1097-0223(199708)17:8<743::AID-PD144>3.0.CO;2-3, 9267898.
32. Jansen MW, von Lindern M, Beug H, Brandenburg H, Wildschut HI, Wladimiroff JW, In 't Veld PA. The use of in vitro expanded erythroid cells in a model system for the isolation of fetal cells from maternal blood. Prenat Diagn 1999, 19:323-329. 10.1002/(SICI)1097-0223(199904)19:4<323::AID-PD534>3.0.CO;2-A, 10327136.
33. Krabchi K, Gros-Louis F, Yan J, Bronsard M, Masse J, Forest JC, Drouin R. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 2001, 60:145-150.
34. Troeger C, Holzgreve W, Hahn S. A comparison of different density gradients and antibodies for enrichment of fetal erythroblasts by MACS. Prenat Diagn 1999, 19:521-526. 10.1002/(SICI)1097-0223(199906)19:6<521::AID-PD578>3.0.CO;2-N, 10416966.
35. Hahn S, Garvin AM, Di Naro E, Holzgreve W. Allele drop-out can occur in alleles differing by a single nucleotide and is not alleviated by preamplification or minor template increments. Genet Test 1998, 2:351-355. 10.1089/gte.1998.2.351, 10464616.
36. Sekizawa A, Samura O, Zhen DK, Falco V, Farina A, Bianchi DW. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2000, 20:886-889. 10.1002/1097-0223(200011)20:11<886::AID-PD942>3.0.CO;2-4, 11113889.
37. Hahn S, Zhong XY, Holzgreve W. Recent progress in non-invasive prenatal diagnosis. Semin Fetal Neonatal Med 2008, 13:57-62. 10.1016/j.siny.2007.11.001, 18207470.
38. Prieto B, Alonso R, Paz A, Candenas M, Venta R, Ladenson JH, Alvarez FV. Optimization of nucleated red blood cell (NRBC) recovery from maternal blood collected using both layers of a double density gradient. Prenat Diagn 2001, 21:187-193. 10.1002/1097-0223(200103)21:3<187::AID-PD32>3.0.CO;2-R, 11260605.
39. Price JO, Elias S, Wachtel SS, Klinger K, Dockter M, Tharapel A, Shulman LP, Phillips OP, Meyers CM, Shook D. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol 1991, 165:1731-1737.
40. Ganshirt-Ahlert D, Burschyk M, Garritsen HS, Helmer L, Miny P, Horst J, Schneider HP, Holzgreve W. Magnetic cell sorting and the transferrin receptor as potential means of prenatal diagnosis from maternal blood. Am J Obstet Gynecol 1992, 166:1350-1355.
41. Busch J, Huber P, Pfluger E, Miltenyi S, Holtz J, Radbruch A. Enrichment of fetal cells from maternal blood by high gradient magnetic cell sorting (double MACS) for PCR-based genetic analysis. Prenat Diagn 1994, 14:1129-1140. 10.1002/pd.1970141206, 7534927.
42. Wachtel SS, Sammons D, Manley M, Wachtel G, Twitty G, Utermohlen J, Phillips OP, Shulman LP, Taron DJ, Muller UR, Koeppen P, Ruffalo TM, Addis K, Porreco R, Murata-Collins J, Parker NB, McGavran L. Fetal cells in maternal blood: recovery by charge flow separation. Hum Genet 1996, 98:162-166. 10.1007/s004390050181, 8698333.
43. Busch J, Huber P, Holtz J, Pfluger E, Radbruch A. Simple and fast "double-MACS" sorting of fetal erythroblasts from maternal blood for PCR-based paternity analysis. Ann N Y Acad Sci 1994, 731:144-146. 10.1111/j.1749-6632.1994.tb55760.x, 7944109.
44. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, Dukes KA, Sullivan LM, Klinger KW, Bischoff FZ, Hahn S, Johnson KL, Lewis D, Wapner RJ, de la Cruz F. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002, 22:609-615. 10.1002/pd.347, 12124698.
45. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997, 61:822-829. 10.1086/514885, 1715976, 9382092.
46. Hung EC, Chiu RW, Lo YM. Detection of circulating fetal nucleic acids: a review of methods and applications. J Clin Pathol 2009, 62:308-313. 10.1136/jcp.2007.048470, 19329710.
47. Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 2009, 15:139-151.
48. Bischoff FZ, Sinacori MK, Dang DD, Marquez-Do D, Horne C, Lewis DE, Simpson JL. Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update 2002, 8:493-500. 10.1093/humupd/8.6.493, 12498419.
49. Adinolfi M, Davies A, Sharif S, Soothill P, Rodeck C. Detection of trisomy 18 and Y-derived sequences in fetal nucleated cells obtained by transcervical flushing. Lancet 1993, 342:403-404. 10.1016/0140-6736(93)92816-C, 8101904.
50. Loke YW, King A, Burrows T, Gardner L, Bowen M, Hiby S, Howlett S, Holmes N, Jacobs D. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens 1997, 50:135-146. 10.1111/j.1399-0039.1997.tb02852.x, 9271823.
51. Bulmer JN, Cioni R, Bussani C, Cirigliano V, Sole F, Costa C, Garcia P, Adinolfi M. HLA-G positive trophoblastic cells in transcervical samples and their isolation and analysis by laser microdissection and QF-PCR. Prenat Diagn 2003, 23:34-39. 10.1002/pd.511, 12533810.
52. Sifakis S, Ghatpande S, Seppo A, Kilpatrick MW, Tafas T, Tsipouras P, Fejgin M, Amiel A. Prenatal diagnosis of trisomy 21 through detection of trophoblasts in cervical smears. Early Hum Dev 2010, 86:311-313. 10.1016/j.earlhumdev.2010.04.005, 20471760.
53. Mandel P, Métals P. Les acides nucléiques du sanguine chez l'homme. CR Acad Sci Paris 1948, 142:241-243.
54. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, Okai T. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001, 47:1856-1858.
55. Birch L, English CA, O'Donoghue K, Barigye O, Fisk NM, Keer JT. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005, 51:312-320. 10.1373/clinchem.2004.042713, 15608152.
56. Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T, Ohama K. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002, 110:75-79. 10.1007/s00439-001-0649-3, 11810300.
57. Papasavva T, Kalikas I, Kyrri A, Kleanthous M. Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms. Ann N Y Acad Sci 2008, 1137:302-308. 10.1196/annals.1448.029, 18837964.
58. Papasavva T, Kalakoutis G, Kalikas I, Neokli E, Papacharalambous S, Kyrri A, Kleanthous M. Noninvasive prenatal diagnostic assay for the detection of beta-thalassemia. Ann N Y Acad Sci 2006, 1075:148-153. 10.1196/annals.1368.020, 17108205.
59. Fucharoen G, Tungwiwat W, Ratanasiri T, Sanchaisuriya K, Fucharoen S. Prenatal detection of fetal hemoglobin E gene from maternal plasma. Prenat Diagn 2003, 23:393-396. 10.1002/pd.607, 12749037.
60. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Rodriguez de Alba M, Lorda-Sanchez I, Diaz-Recasens J, Gallardo E, Ayuso C, Ramos C. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002, 22:946-948. 10.1002/pd.439, 12378583.
61. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000, 356:1170. 10.1016/S0140-6736(00)02767-7, 11030304.
62. Ding C, Chiu RW, Lau TK, Leung TN, Chan LC, Chan AY, Charoenkwan P, Ng IS, Law HY, Ma ES, Xu X, Wanapirak C, Sanguansermsri T, Liao C, Ai MA, Chui DH, Cantor CR, Lo YM. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004, 101:10762-10767. 10.1073/pnas.0403962101, 490008, 15247415.
63. Li Y, Hahn D, Wenzel F, Holzgreve W, Hahn S. Detection of SNPs in the plasma of pregnant women and in the urine of kidney transplant recipients by mass spectrometry. Ann N Y Acad Sci 2006, 1075:144-147. 10.1196/annals.1368.019, 17108204.
64. Tang K, Fu DJ, Julien D, Braun A, Cantor CR, Koster H. Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci USA 1999, 96:10016-10020. 10.1073/pnas.96.18.10016, 17834, 10468554.
65. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004, 50:1002-1011. 10.1373/clinchem.2003.029835, 15073090.
66. Lo YM, Chiu RW. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. Clin Chem 2008, 54:461-466. 10.1373/clinchem.2007.100016, 18202154.
67. Dhallan R, Au WC, Mattagajasingh S, Emche S, Bayliss P, Damewood M, Cronin M, Chou V, Mohr M. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 2004, 291:1114-1119. 10.1001/jama.291.9.1114, 14996781.
68. Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, Barry J, Betz J, Franz K, Gold K, Vallecillo B, Varney J. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 2007, 369:474-481. 10.1016/S0140-6736(07)60115-9, 17292767.
69. Chinnapapagari SK, Holzgreve W, Lapaire O, Zimmermann B, Hahn S. Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin Chem 2005, 51:652-655. 10.1373/clinchem.2004.042119, 15738521.
70. Chung GT, Chiu RW, Chan KC, Lau TK, Leung TN, Lo YM. Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin Chem 2005, 51:655-658. 10.1373/clinchem.2004.042168, 15738522.
71. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005, 37:853-862. 10.1038/ng1598, 16007088.
72. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007, 128:683-692. 10.1016/j.cell.2007.01.029, 17320506.
73. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999, 59:67-70.
74. Lo YM, Wong IH, Zhang J, Tein MS, Ng MH, Hjelm NM. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res 1999, 59:3899-3903.
75. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999, 59:71-73.
76. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-9826. 10.1073/pnas.93.18.9821, 38513, 8790415.
77. Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, To KF, Tong JH, Yuen RK, Shum AS, Chan JK, Chan LY, Yuen JW, Tong YK, Weier JF, Ferlatte C, Leung TN, Lau TK, Lo KW, Lo YM. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007, 170:941-950. 10.2353/ajpath.2007.060641, 1864885, 17322379.
78. Tong YK, Chiu RW, Akolekar R, Leung TY, Lau TK, Nicolaides KH, Lo YM. Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One 2010, 5:e15244. 10.1371/journal.pone.0015244, 3004793, 21249119.
79. Tong YK, Jin S, Chiu RW, Ding C, Chan KC, Leung TY, Yu L, Lau TK, Lo YM. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 2010, 56:90-98. 10.1373/clinchem.2009.134114, 19850629.
80. Tong YK, Ding C, Chiu RW, Gerovassili A, Chim SS, Leung TY, Leung TN, Lau TK, Nicolaides KH, Lo YM. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem 2006, 52:2194-2202. 10.1373/clinchem.2006.076851, 17040955.
81. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001, 29:E65-65. 10.1093/nar/29.13.e65, 55789, 11433041.
82. Fazzari MJ, Greally JM. Epigenomics: beyond CpG islands. Nat Rev Genet 2004, 5:446-455. 10.1038/nrg1349, 15153997.
83. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, Haefliger C, Horton R, Howe K, Jackson DK, Kunde J, Koenig C, Liddle J, Niblett D, Otto T, Pettett R, Seemann S, Thompson C, West T, Rogers J, Olek A, Berlin K, Beck S. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006, 38:1378-1385. 10.1038/ng1909, 3082778, 17072317.
84. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, Tomazou EM, Backdahl L, Johnson N, Herberth M, Howe KL, Jackson DK, Miretti MM, Fiegler H, Marioni JC, Birney E, Hubbard TJ, Carter NP, Tavare S, Beck S. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 2008, 18:1518-1529. 10.1101/gr.077479.108, 2527707, 18577705.
85. Tsui NB, Chiu RW, Ding C, El-Sheikhah A, Leung TN, Lau TK, Nicolaides KH, Lo YM. Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms. Clin Chem 2005, 51:2358-2362. 10.1373/clinchem.2005.056978, 16306096.
86. Geifman-Holtzman O, Ober Berman J. Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood. Expert Rev Mol Diagn 2008, 8:727-751. 10.1586/14737159.8.6.727, 18999924.
87. Bahtiyar MO, Copel JA, Mahoney MJ, Buhimschi IA, Buhimschi CS. Proteomics: a novel methodology to complement prenatal diagnosis of chromosomal abnormalities and inherited human diseases. Am J Perinatol 2007, 24:167-181. 10.1055/s-2007-972927, 17372862.
88. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One 2010, 5:e10439. 10.1371/journal.pone.0010439, 2862719, 20454671.
89. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011, 342:c7401. 10.1136/bmj.c7401, 3019239, 21224326.
90. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, Dean J, Tang L, Hutchison D, Lu T, Wang H, Angkachatchai V, Oeth P, Cantor CR, Bombard A, van den Boom D. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011, 204:205 e1-11.
91. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011, 13:913-920. 10.1097/GIM.0b013e3182368a0e, 22005709.
92. Chen EZ, Chiu RWK, Sun H, Akolekar R, Chan KCA, Leung TY, Jiang P, Zheng YWL, Lun FMF, Chan LYS, Jin Y, Go ATJI, Lau ET, To WWK, Leung WC, Tang RYK, Au-Yeung SKC, Lam H, Kung YY, Zhang X, van Vugt JMG, Minekawa R, Tang MHY, Wang J, Oudejans CBM, Lau TK, Nicolaides KH, Lo YMD. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011, 6:e21791. 10.1371/journal.pone.0021791, 3130771, 21755002.
93. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011, 57:1042-1049. 10.1373/clinchem.2011.165910, 21519036.
94. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012, 14:296-305. 10.1038/gim.2011.73, 22281937.
95. Sparks AB, Wang ET, Struble CA, Barrett W, Stokowski R, McBride C, Zahn J, Lee K, Shen N, Doshi J, Sun M, Garrison J, Sandler J, Hollemon D, Pattee P, Tomita-Mitchell A, Mitchell M, Stuelpnagel J, Song K, Oliphant A. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012, 32:3-9. 10.1002/pd.2922, 22223233.
96. van den Oever JM, Balkassmi S, Verweij EJ, van Iterson M, Adama van Scheltema PN, Oepkes D, van Lith JM, Hoffer MJ, den Dunnen JT, Bakker E, Boon EM. Single Molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. Clin Chem 2012, 58:699-706. 10.1373/clinchem.2011.174698, 22278607.
97. Peters D, Chu T, Yatsenko SA, Hendrix N, Hogge WA, Surti U, Bunce K, Dunkel M, Shaw P, Rajkovic A. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011, 365:1847-1848. 10.1056/NEJMc1106975, 22070496.
98. Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, Carter NP, Patsalis PC. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 2009, 174:1609-1618. 10.2353/ajpath.2009.081038, 2671250, 19349366.
99. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal specific DNA methylation ratio permits non-invasive prenatal diagnosis of trisomy 21. Nat Med 2011, 17:510-513. 10.1038/nm.2312, 21378977.
100. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000, 46:1832-1834.
101. Hasselmann DO, Rappl G, Tilgen W, Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 2001, 47:1488-1489.
102. Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, Lo ES, Rainer TH, Johnson PJ, Lo YM. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002, 48:1212-1217.
103. Tsui NB, Ng EK, Lo YM. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 2002, 48:1647-1653.
104. Tsui NB, Chim SS, Chiu RW, Lau TK, Ng EK, Leung TN, Tong YK, Chan KC, Lo YM. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet 2004, 41:461-467. 10.1136/jmg.2003.016881, 1735812, 15173234.
105. Tsui NB, Lo YM. A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma. Methods Mol Biol 2008, 444:275-289. 10.1007/978-1-59745-066-9_22, 18425489.
106. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, Ding C. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007, 13:218-223. 10.1038/nm1530, 17206148.
107. Oudejans CB, Go AT, Visser A, Mulders MA, Westerman BA, Blankenstein MA, van Vugt JM. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem 2003, 49:1445-1449. 10.1373/49.9.1445, 12928224.
108. Tsui NB, Akolekar R, Chiu RW, Chow KC, Leung TY, Lau TK, Nicolaides KH, Lo YM. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 2010, 56:73-81. 10.1373/clinchem.2009.132662, 19892844.
109. Tsui NB, Wong BC, Leung TY, Lau TK, Chiu RW, Lo YM. Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study. Prenat Diagn 2009, 29:1031-1037. 10.1002/pd.2340, 19650060.
110. Lo YM, Lun FM, Chan KC, Tsui NB, Chong KC, Lau TK, Leung TY, Zee BC, Cantor CR, Chiu RW. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007, 104:13116-13121. 10.1073/pnas.0705765104, 1934923, 17664418.
111. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 2007, 79:7576-7579. 10.1021/ac0709394, 17715994.
112. Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci USA 1999, 96:9236-9241. 10.1073/pnas.96.16.9236, 17763, 10430926.
113. SEQUENOM, Inc. , http://www.sequenom.com
114. Aria Diagnostics, Inc. , http://www.ariadx.com
115. Verinata Health, Inc. , http://www.verinata.com
116. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012, 119:890-901. 10.1097/AOG.0b013e31824fb482, 22362253.
117. NIPD Genetics Ltd. , http://www.nipd.com
118. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. 10.1186/1471-2288-3-25, 305345, 14606960.
119. Lo YM. Noninvasive prenatal diagnosis in 2020. Prenat Diagn 2010, 30:702-703. 10.1002/pd.2516, 20572103.